Literature DB >> 15624094

Rosiglitazone and lipid metabolism.

E Ferrannini1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15624094     DOI： 10.1007/s00125-004-1616-z

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  8 in total

1.  Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone.

Authors:  J Sakamoto; H Kimura; S Moriyama; H Odaka; Y Momose; Y Sugiyama; H Sawada
Journal:  Biochem Biophys Res Commun       Date:  2000-11-30       Impact factor: 3.575

Review 2.  Thiazolidinediones.

Authors:  Hannele Yki-Järvinen
Journal:  N Engl J Med       Date:  2004-09-09       Impact factor: 91.245

3.  The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes.

Authors:  G D Tan; B A Fielding; J M Currie; S M Humphreys; M Désage; K N Frayn; M Laville; H Vidal; F Karpe
Journal:  Diabetologia       Date:  2004-12-24       Impact factor: 10.122

Review 4.  The mechanisms of action of PPARs.

Authors:  Joel Berger; David E Moller
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

5.  Effects of troglitazone on insulin action and cardiovascular risk factors in patients with non-insulin-dependent diabetes.

Authors:  A M Sironi; S Vichi; A Gastaldelli; N Pecori; R Anichini; E Foot; G Seghieri; E Ferrannini
Journal:  Clin Pharmacol Ther       Date:  1997-08       Impact factor: 6.875

6.  Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes.

Authors:  Mirja Tiikkainen; Anna-Maija Häkkinen; Elena Korsheninnikova; Tuulikki Nyman; Sari Mäkimattila; Hannele Yki-Järvinen
Journal:  Diabetes       Date:  2004-08       Impact factor: 9.461

7.  Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects.

Authors:  Kirsi A Virtanen; Kirsti Hällsten; Riitta Parkkola; Tuula Janatuinen; Fredrik Lönnqvist; Tapio Viljanen; Tapani Rönnemaa; Juhani Knuuti; Risto Huupponen; Peter Lönnroth; Pirjo Nuutila
Journal:  Diabetes       Date:  2003-02       Impact factor: 9.461

8.  Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes.

Authors:  Julia Tonelli; Weijie Li; Preeti Kishore; Utpal B Pajvani; Elize Kwon; Charles Weaver; Philipp E Scherer; Meredith Hawkins
Journal:  Diabetes       Date:  2004-06       Impact factor: 9.461
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.